Display options
Share it on

J Chemother. 2021 Jul 21;1-6. doi: 10.1080/1120009X.2021.1955203. Epub 2021 Jul 21.

Oral fosfomycin for treating lower urinary tract infections due to multidrug-resistant .

Journal of chemotherapy (Florence, Italy)

Meltem Polat, Aslınur Ozkaya-Parlakay, Anıl Tapısız, Soner Sertan Kara, Selçuk Yüksel

Affiliations

  1. Department of Pediatric Infectious Diseases, Erzurum Research and Training Hospital, Erzurum, Turkey.
  2. Faculty of Medicine, Department of Pediatric Infectious Diseases, Pamukkale University, Denizli, Turkey.
  3. Department of Pediatric Infectious Diseases, Yildirim Beyazit University Ankara City Hospital, Ankara, Turkey.
  4. Department of Pediatric Infectious, School of Medicine, Diseases Gazi University, Ankara, Turkey.
  5. Faculty of Medicine, Department of Pediatric Nephrology, Pamukkale University, Denizli, Turkey.

PMID: 34286658 DOI: 10.1080/1120009X.2021.1955203

Abstract

Fosfomycin trometamol (FT) has shown promising

Keywords: Escherichia coli; Fosfomycin trometamol; female adolescents; lower urinary tract infections; multidrug-resistant; oral

Publication Types